Post #2544551
2026-05-06 01:40 UTC
@kuba@toot.kuba-orlik.name
Part1/2
From the same scientist(https://dx.doi.org/10.1016/s2215-0366(26)00015-5):
Our meta-analysis revealed that a combination of cannabidiol and delta-9-tetrahydrocannabinol reduced cannabis withdrawal symptoms (SMD -0·29, 95% CI -0·57 to -0·02) and weekly grams of cannabis use (-1·00, -1·69 to -0·30) among those with cannabis use disorder, and a reduction in tic severity among those with tic or Tourette's Syndrome (-0·68, -1·03 to -0·34) compared with placebo.
Replies (1)
-
@felixte@mstdn.social 2026-05-06 01:40
@kuba@toot.kuba-orlik.name Part2/2 Any cannabinoid type led to an increase in sleep time as recorded by an electronic device (0·54, 0·14 to 0·95) and sleep diary (0·55, 0·01 to 1·09) among those with insomnia. There was a reduction in autistic traits (-0·36, -0·66 to -0·07) among those with autism spectrum disorder.